2-甲基-1-(3-甲基苯基)哌嗪，CAS 登记号 35947-10-5，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2-甲基-1-(3-甲基苯基)哌嗪 的 CAS 号：35947-10-5，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2-Methyl-1-(3-methylphenyl)piperazine · CAS 35947-10-5 · C12H18N2. UNII HMS1378H01.
| CAS Registry Number | 35947-10-5 |
|---|---|
| PubChem CID | 2723804 |
| Molecular formula | C12H18N2 |
| IUPAC name | 2-methyl-1-(3-methylphenyl)piperazine |
| UNII (FDA) | HMS1378H01 |
| Molecular Weight | 190.28 |
|---|---|
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 190.146998583 |
| Monoisotopic Mass | 190.146998583 |
| Topological Polar Surface Area | 15.3 |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H312 (100%), H315 (100%), H318 (100%), H332 (100%), H335 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]
2-methyl-1-(3-methylphenyl)piperazine; 2-Methyl-1-(m-tolyl)piperazine; EINECS 252-810-0; RefChem:474867; 252-810-0; 35947-10-5; MFCD00044835; 2-methyl-1-m-tolylpiperazine; ChemDiv2_003323; Piperazine,2-methyl-1-(3-methylphenyl)-; SCHEMBL335553; 2-methyl-1-rn-tolylpiperazine; 2-Methyl-1-m-tolyl-piperazine; SCHEMBL1365728; SCHEMBL30996886; HMS1378H01
CAS 35947-10-5; molecular formula C12H18N2; molecular weight — g/mol.
2-methyl-1-(3-methylphenyl)piperazine, 2-Methyl-1-(m-tolyl)piperazine, EINECS 252-810-0, RefChem:474867, 252-810-0, 35947-10-5.
Hazard statements reported: H302, H312, H315, H318, H332.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.